GSK3B and early-onset autosomal dominant Alzheimer disease: In the pathogenesis of Alzheimer’s disease, theoverexpressionof glycogen synthase kinase-3β (GSK-3β) stands out dueto its multifaced nature, as it contributes to the promotion of amyloidβ and tau protein accumulation, as well as neuroinflammatoryprocesses.